Navigation Links
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Date:8/21/2007

INDIANAPOLIS, Aug. 21 /PRNewswire-FirstCall/ -- New data suggest that patients with fibromyalgia treated with 60mg or 120mg of Cymbalta(R) (duloxetine HCl) experienced greater reduction in pain severity beginning one week after starting duloxetine than those taking placebo (sugar pill), as measured by the Brief Pain Inventory Average Pain Score (BPI). The study, which included patients with and without depression, also showed greater improvements in patients taking duloxetine than in those taking placebo in scores on the Patient's Global Impression of Improvement questionnaire (PGI- I), which measures how the patient has felt overall since beginning to take the medication. The data were presented today at the 2007 Congress of the International MYOPAIN Society in Washington, D.C.

At three months, patients treated with 60mg per day or 120mg per day of duloxetine showed significantly greater reduction in pain and improvement in PGI-I scores compared with patients taking placebo. At three months, more patients treated with either 60mg or 120mg of duloxetine showed significantly greater reduction in pain as measured by a 30 percent improvement in baseline BPI scores (50.7 percent and 52.1 percent, respectively) compared with patients taking placebo (36 percent).

"Fibromyalgia is a chronic illness, characterized by widespread pain, tenderness and fatigue. It can also affect the patient's overall emotional health and well-being," said I. Jon Russell, M.D., Ph.D., associate professor of medicine at the University of Texas Health Science Center in San Antonio. "Between 34 percent(1) and 62 percent(2) of those living with fibromyalgia will experience depression at some point in their lives. In this study, which included patients with and without depression, duloxetine reduced the pain associated with fibromyalgia."

Fibromyalgia is estimated to affect 2 percent to 4 percent of the U.S. population(3), the majority being women. In addition to chronic pai
'/>"/>

SOURCE Eli Lilly and Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7. Juli 2015 BioClinica®, Inc ... klinische Studien, gab heute bekannt, dass es mit ... bei Gewinnung und Erhalt von Patienten übernommen hat. ... MediciGlobal , Ltd. und Access to Patients, LLC. ... Dienst zum Auffinden von Patienten, die für die ...
(Date:7/7/2015)... 7, 2015   InspireMD, Inc. (NYSE ... in embolic protection systems ("EPS"), today announced that ... integrated with MicroNet ™ has received the ... Product Innovation Award.  Through active market research efforts, ... consultants recognize the successful introduction of new and ...
(Date:7/7/2015)... -- Essentialis, a venture-backed company focused on the development of K ... and metabolic diseases, today announced that Dr. Neil M. ... at the Cantor Fitzgerald Inaugural Healthcare Conference. ... 8, 2015 Time: 8:00 AM Eastern Time Location: ... Essentialis is a Carlsbad ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5
... NEW YORK, Jan. 13, 2012  The New Year brings hope ... Society (ACS) predicts another 240,000 U.S. men will receive this ... battle we are winning. Prostate cancer -specific deaths dropped ... PSA screening and improved surgical treatment, in the form ...
... 2012 The U.S. Food and Drug Administration today ... by W.L. Gore and Associates Inc. to include treatment ... aortic transection). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... endovascular graft approved by the FDA to treat a ...
Cached Medicine Technology:PSA Testing and Robotic Surgery Take on Prostate Cancer 2PSA Testing and Robotic Surgery Take on Prostate Cancer 3FDA Expands Use of Endovascular Graft to Treat Aortic Tears 2
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed to ... days at work is knowing that there is hopefully a vacation to look forward ... as imagined. Planning for a vacation can be quite stressful, and it’s difficult sometimes ...
(Date:7/7/2015)... MA (PRWEB) , ... July 07, 2015 , ... The ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... ... SC&H Group, a leading audit, tax, and consulting firm, recently hosted its 9th ... volunteering efforts. , On an annual basis, in coordination with Business Volunteers Maryland ... Baltimore and Washington D.C. , This year, SC&H Group’s team in Maryland ...
(Date:7/7/2015)... Rockville, Maryland (PRWEB) , ... July 07, 2015 ... ... mobile app to further enhance the experience for its patient community using its ... The app allows patients with primary immunodeficiency diseases (PI) to easily track their ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... smart and flexible behavior early in life even though ... , In a series of experiments, scientists tested how well ... of information to choose objects in a group. In some ... and in some cases based on shape. , Results showed ...
... and Inaccurate Insurance Payments Add Cost, Inefficiency to,Health ... help reduce the,substantial administrative burden of ensuring accurate ... (AMA) today,launched the Cure for Claims campaign to ... with health insurers, and unveiled the first AMA,National ...
... the world,s leading news,service for the medical technology industry ... of Parliament have been at risk of exposure to,high ... three years. This news comes despite warnings from experts ... that the material,discovered in 2005 was safely contained., ...
... called ,tastants, help you feel full, study suggests , , MONDAY, ... food with calorie-free seasonings and sweeteners may help you feel ... a U.S. study that suggests this may be a new ... of "tastants" -- substances that can stimulate the sense of ...
... detects and treats cancer cells that are resistant to ... the laboratory and could eventually prove beneficial for cancer ... The new system targets oxygen-deficient hypoxic cancer cells that ... the cells, survival and makes them unresponsive to most ...
... NEW ORLEANS, La.Positron emission tomography (PET) could be ... who are likely to respond well to treatment ... approved for use by the U.S. Food and ... Meeting. PET imaging allows practitioners to identify patients ...
Cached Medicine News:Health News:Children learn smart behaviors without knowing what they know 2Health News:Children learn smart behaviors without knowing what they know 3Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 2Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 3Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 4Health News:Palace of Westminster Asbestos Problem Ignored 2Health News:Flavoring Food May Promote Weight Loss 2Health News:Flavoring Food May Promote Weight Loss 3Health News:New therapy shows promise for fighting treatment-resistant cancer cells 2Health News:Every patient is unique: Individualized therapies for non-Hodgkin's lymphoma 2
... Analyzer is an exceptional platform for ... microplate-based assays. The system's programming features ... laboratories. For low volume users, the ... assays with common features to complete ...
... been in trial for 14 years -- ... Gender Test employs cutting-edge, patent-pending technology to ... sensitivity and unsurpassed accuracy. The technique traces ... the maternal blood to determine gender. Here's ...
... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
... protein is a 185 kD trans-membrane glycoprotein ... cases of breast cancer show an amplification ... Since the introduction of Herceptin® as a ... testing of Her-2/neu in breast carcinoma has ...
Medicine Products: